Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1773515018 | Paracetamol + phenyltoloxamine citrate + salicylamide | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 1774801019 | Acetaminophen + phenyltoloxamine citrate + salicylamide | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3490647016 | Product containing paracetamol and phenyltoloxamine citrate and salicylamide (medicinal product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3494842017 | Product containing acetaminophen and phenyltoloxamine citrate and salicylamide | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3494843010 | Product containing paracetamol and phenyltoloxamine citrate and salicylamide | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing paracetamol and phenyltoloxamine citrate and salicylamide | Is a | Product containing paracetamol and phenyltoloxamine citrate | false | Inferred relationship | Some | ||
| Product containing paracetamol and phenyltoloxamine citrate and salicylamide | Is a | Product containing salicylamide (medicinal product) | false | Inferred relationship | Some | ||
| Product containing paracetamol and phenyltoloxamine citrate and salicylamide | Has active ingredient | Salicylamide | false | Inferred relationship | Some | ||
| Product containing paracetamol and phenyltoloxamine citrate and salicylamide | Has active ingredient | Ethanolamine | false | Inferred relationship | Some | ||
| Product containing paracetamol and phenyltoloxamine citrate and salicylamide | Has active ingredient | Paracetamol | false | Inferred relationship | Some | ||
| Product containing paracetamol and phenyltoloxamine citrate and salicylamide | Has active ingredient | Phenyltoloxamine (substance) | false | Inferred relationship | Some | ||
| Product containing paracetamol and phenyltoloxamine citrate and salicylamide | Has active ingredient | Phenyltoloxamine citrate | false | Inferred relationship | Some | ||
| Product containing paracetamol and phenyltoloxamine citrate and salicylamide | Has active ingredient | Cardiovascular agent (substance) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) | Is a | False | Product containing paracetamol and phenyltoloxamine citrate and salicylamide | Inferred relationship | Some | |
| Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet | Is a | False | Product containing paracetamol and phenyltoloxamine citrate and salicylamide | Inferred relationship | Some |
Reference Sets
Concept inactivation indicator reference set
Description inactivation indicator reference set
FHIR